New research suggests that the lessening of amyloid-beta in the brain is behind cognitive decline in Alzheimer's and boosting ...

A study published Wednesday in Nature Neuroscience sheds light into how amyloid-beta and tau proteins impact brain activity ...

Researchers discover how amyloid-β and tau pathologies interact to drive early neurophysiological changes and cognitive ...

Amyloid-beta and tau proteins have long been associated with Alzheimer's disease. The pathological buildup of these proteins ...

Boosting a certain brain protein could help slow the progression of Alzheimer’s disease, a new study has found. The ...

A new study helps explain why having ApoE4—the gene variant most closely linked to Alzheimer's disease—increases the risk of ...

The scientists looked at two brain scans and found that areas with more amyloid-beta showed increased brain activity, with ...

Much of the brain is made up of a constellation of star-shaped cells called astrocytes, which play vital roles in immunity, ...

A study shows that rising levels of brain protein Aβ42, not the reduction of amyloid plaques, better explains the cognitive ...

The FDA’s approval of Kisunla demonstrates a positive change in Alzheimer disease management. Offering illness pathology therapy and the option of treatment conclusion after reaching therapeutic goals ...

Along with amyloid beta, Tau is a key protein implicated in the disease. In April, Roche secured FDA breakthrough designation ...

GE Healthcare's MIM Software announces the receipt of FDA clearance for its Centiloid scaling tool to perform PET-based ...